 |
nivolumab |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-16 00:00:00 |
| Sponsor | Bristol-Myers Squibb Company;5 Research Parkway;Wallingford, Connecticut, 06492 |
| |
nivolumab |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-16 00:00:00 |
| Sponsor | Bristol-Myers Squibb Company;5 Research Parkway;Wallingford, Connecticut, 06492 |